Literature DB >> 1883513

Regulatory mechanisms of host responsiveness to endotoxin (lipopolysaccharide).

J Mathison1, P Tobias, E Wolfson, R Ulevitch.   

Abstract

During Gram-negative endotoxemia, precise regulation of monocyte/macrophage (M phi) responsiveness to lipopolysaccharide (LPS) is critical to preserve host defense while avoiding complications such as organ failure and death. We will discuss regulation of LPS-M phi interactions by LPS-binding plasma proteins and by LPS-induced changes in M phi responsiveness. Upon exposure to plasma, LPS binds to either lipoproteins or LPS-binding protein (LBP; a 60-kilodalton glycoprotein with a high-affinity binding site for the lipid A moiety of rough and smooth LPS). The LPS-LBP complex stimulates the M phi by binding to its cellular receptor, CD14 (a monocyte/M phi-specific, phosphatidylinositol-anchored surface glycoprotein). Pretreatment of whole blood with anti-CD 14 monoclonal antibody reduces the responsiveness of monocytes to LPS [determined by tumor necrosis factor-alpha (TNF-alpha) release]at least 10-fold. Similarly, cellular responsiveness to LPS is diminished at least 100-fold by depletion of plasma LBP with anti-LBP antibody. Compared to LPS-LBP induction of TNF-alpha, LPS-lipoprotein complexes are as much as 10,000-fold less active. Thus, partitioning of LPS between LBP and lipoproteins markedly influences M phi responsiveness to LPS. LPS also directly induces M phi hyporesponsiveness to itself by a process known as adaptation; exposure of M phi to less than or equal to LPS/ml (subthreshold for TNF induction) for 6-9 reduces the sensitivity of the M phi to subsequent challenge up to 1,000-fold, so that 1 microgram/ml rather than 1 ng/ml of LPS is required for maximal induction of TNF-alpha.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883513     DOI: 10.1159/000163641

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  16 in total

1.  Distribution and kinetics of lipoprotein-bound endotoxin.

Authors:  J H Levels; P R Abraham; A van den Ende; S J van Deventer
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis.

Authors:  I Stríz; Y M Wang; H Teschler; C Sorg; U Costabel
Journal:  Lung       Date:  1993       Impact factor: 2.584

3.  Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes.

Authors:  B Weidemann; J Schletter; R Dziarski; S Kusumoto; F Stelter; E T Rietschel; H D Flad; A J Ulmer
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.

Authors:  M Arditi; J Zhou; R Dorio; G W Rong; S M Goyert; K S Kim
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Differential binding of bacterial lipopolysaccharide to bovine peripheral-blood leukocytes.

Authors:  P N Bochsler; J M Maddux; N R Neilsen; D O Slauson
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

6.  Enhancement of lipopolysaccharide-induced tumor necrosis factor secretion by hyperimmune serum from chronic infected patients.

Authors:  G Kronborg; A Fomsgaard; N Høiby
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

7.  Role for circulating lipoproteins in protection from endotoxin toxicity.

Authors:  K R Feingold; J L Funk; A H Moser; J K Shigenaga; J H Rapp; C Grunfeld
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.

Authors:  M Arditi; J Zhou; S H Huang; P M Luckett; M N Marra; K S Kim
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

Review 9.  Endotoxemia: methods of detection and clinical correlates.

Authors:  J C Hurley
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

10.  Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.

Authors:  M G Netea; P N Demacker; B J Kullberg; O C Boerman; I Verschueren; A F Stalenhoef; J W van der Meer
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.